date:Jan 17, 2013
utraceutical revenues increased by 29% to $6,603,000. Adjusted EBITDA decreased to $432,000, down from $1,081,000. Net loss reached $10,883,0002, compared to a net income of $869,000 for the corresponding period in the previous year.